In clinical research, patients with advanced non-small cell lung cancer (NSCLC) that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA® (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel.
A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.
A new study by Dutch researchers has found that adolescents may suffer from severe symptoms of post-traumatic stress when a parent is recently diagnosed with cancer and that parents tend to underestimate the problems.
A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16.
Childhood brainstem gliomas (BSGs) are rare but can be very difficult to treat successfully and they tend to have poor survival rates. However, a team of Spanish researchers have found that a chemotherapy regimen of irinotecan and cisplatin (I/C) produced rapid clinical responses and shrank the tumours by more than 20 percent in all six children enrolled in a clinical trial.
At a time when tens of millions of patients worldwide endure disabling injuries or die each year from unsafe medical practices, the United Nations health agency and its partners called for increased research into patient safety, including the risks posed by care- and surgery-related infections, adverse drug effects and unsafe injections.
Italian scientists will announce today (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer. Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference (ECCO 14) that he and his team have found a widespread mechanism for the stimulation of tumour growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.
Cancer cells circulating in the blood, or circulating tumour cells (CTCs), are known to be associated with a bad prognosis in women with metastatic breast cancer.
Quality of life after treatment for endometrial cancer can be significantly improved by the use of vaginal brachytherapy, where radiotherapy is delivered internally using a vaginal cylinder, the European Cancer Conference (ECCO 14) heard today (Monday September 24).
A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14) today (Monday 24 September).